Document Detail


Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome.
MedLine Citation:
PMID:  3373258     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The presenting features and clinical outcome of acute nonlymphoblastic leukemia (ANLL) in infants and older children were compared to identify any differences that might suggest methods to improve therapy. Twelve of the 29 infants were boys and 17 were girls, with ages ranging from two days to 12 months (median, 7 months). By comparison with 222 patients greater than 1 year of age, infants were significantly more likely to have monoblastic or myelomonoblastic leukemia (P less than .0001), chloroma (P less than .0001), marked hepatomegaly (P = .001), and high leukocyte count (P = .005) and were less likely to have Auer rods (P less than .001). Each of these features except leukocyte count showed an association with infant ANLL in a multivariate analysis. Twenty-four (83%) of the infants attained a complete remission, a rate that was not significantly different from that of the older children. Even though infants had a significantly higher CNS relapse rate (P = .003), their event-free survival times were no different than those of older children (P = .74). Ten of the infants remain in initial complete remission for 5+ to 112+ months (median, 52+ months). Infants with ANLL did not have a poorer prognosis than older patients in our study; future protocols for this age group should emphasize more effective systemic therapy, preferably including an epipodophyllotoxin, as well as improved treatment for subclinical CNS leukemia.
Authors:
C H Pui; D K Kalwinsky; M J Schell; C A Mason; J Mirro; G V Dahl
Related Documents :
19665068 - Etv6-runx1 fusion gene and additional genetic changes in infant leukemia: a genome-wide...
10452428 - Abdominal distention and shock in an infant.
18385028 - Extirpation of the primary canine tooth follicles: a form of infant oral mutilation.
8932918 - Maternal exposure to potential inhibitors of dna topoisomerase ii and infant leukemia (...
24462418 - Hyperferritinemia in neonatal and infantile human parechovirus-3 infection in compariso...
9643618 - Distribution and excretion of venlafaxine and o-desmethylvenlafaxine in human milk.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of clinical oncology : official journal of the American Society of Clinical Oncology     Volume:  6     ISSN:  0732-183X     ISO Abbreviation:  J. Clin. Oncol.     Publication Date:  1988 Jun 
Date Detail:
Created Date:  1988-07-08     Completed Date:  1988-07-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8309333     Medline TA:  J Clin Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1008-13     Citation Subset:  IM    
Affiliation:
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Brain Neoplasms / therapy*
Female
Humans
Infant
Infant, Newborn
Leukemia / mortality,  pathology,  therapy*
Male
Recurrence
Grant Support
ID/Acronym/Agency:
CA 20180/CA/NCI NIH HHS; CA 21765/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Astrocytoma in children: 14 years' experience at Stanford University Medical Center.
Next Document:  Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease.